BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28698986)

  • 1. Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.
    Kang SH; Kim MY; Baik SK
    Hepatol Int; 2018 Feb; 12(Suppl 1):112-121. PubMed ID: 28698986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension.
    Bosch J; Pizcueta MP; Fernández M; Feu F; Cirera I; Luca A; García-Pagán JC
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):425-36. PubMed ID: 1421593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New cellular and molecular targets for the treatment of portal hypertension.
    Gracia-Sancho J; Maeso-Díaz R; Fernández-Iglesias A; Navarro-Zornoza M; Bosch J
    Hepatol Int; 2015 Apr; 9(2):183-91. PubMed ID: 25788198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.
    Bosch J; Abraldes JG; Fernández M; García-Pagán JC
    J Hepatol; 2010 Sep; 53(3):558-67. PubMed ID: 20561700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of portal hypertension.
    Berzigotti A; Bosch J
    Clin Liver Dis; 2014 May; 18(2):303-17. PubMed ID: 24679496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal hypertension: from bedside to bench.
    Groszmann RJ; Abraldes JG
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S125-30. PubMed ID: 15758647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of portal hypertension.
    Iwakiri Y
    Clin Liver Dis; 2014 May; 18(2):281-91. PubMed ID: 24679494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.
    Bosch J; Groszmann RJ; Shah VH
    J Hepatol; 2015 Apr; 62(1 Suppl):S121-30. PubMed ID: 25920081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives.
    Garbuzenko DV; Arefyev NO; Kazachkov EL
    World J Gastroenterol; 2018 Sep; 24(33):3738-3748. PubMed ID: 30197479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension. Update on pathophysiology and management.
    Chatila R
    J Med Liban; 2001; 49(2):101-5. PubMed ID: 11910964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and portal hypertension.
    González-Abraldes J; García-Pagán JC; Bosch J
    Metab Brain Dis; 2002 Dec; 17(4):311-24. PubMed ID: 12602508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapies for portal hypertension in cirrhosis.
    Nair H; Berzigotti A; Bosch J
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):167-81. PubMed ID: 27148904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology and pathophysiology of portal hypertension.
    Reichen J
    Z Gastroenterol; 1988 Sep; 26 Suppl 2():3-7. PubMed ID: 3055716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.